Cel Sci (CVM) Accumulated Expenses (2010 - 2026)
Cel Sci's Accumulated Expenses came in at $462,121 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 2.8% from $475,602 a year earlier but up 14.3% from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Accumulated Expenses (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Cel Sci's Accumulated Expenses was $711,820, up 25.8% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- Going back by fiscal year, Accumulated Expenses was $566,042 in FY2024 (-46.1%), $1.05 million in FY2023 (+24.6%), $842,492 in FY2022 (-1.9%) and $859,216 in FY2021 (+68.3%).
- The five-year range for quarterly Accumulated Expenses is $404,220 (fiscal Q2 2026) to $1.27 million (fiscal Q3 2024).
- Year-over-year, Accumulated Expenses has declined for three consecutive quarters, with an average decline of 29.6% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in fiscal Q2 2022 (growth of 103.9%), and the weakest in fiscal Q3 2025 (a decline of 62.6%).
- Business Quant data shows CVM's Accumulated Expenses at $404,220 (Q2 2026), $430,460 (Q1 2026) and $711,820 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Cel Sci | 3.69 Mn | -21.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 462,121.00 |
| Mar 31, 2026 | 404,220.00 |
| Dec 31, 2025 | 430,460.00 |
| Sep 30, 2025 | 711,820.00 |
| Jun 30, 2025 | 475,602.00 |
| Mar 31, 2025 | 593,551.00 |
| Dec 31, 2024 | 621,601.00 |
| Sep 30, 2024 | 566,042.00 |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 985,657.00 |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 800,838.00 |
| Sep 30, 2022 | 842,492.00 |
| Jun 30, 2022 | 992,945.00 |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 899,901.00 |
| Sep 30, 2021 | 859,216.00 |
API Access
Cel Sci Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();